Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q5T6V5
UPID:
QNG1_HUMAN
Alternative names:
Q-nucleotide N-glycosylase 1; Queuine salvage protein QNG1; Queuosine-nucleotide N-glycosylase/hydrolase
Alternative UPACC:
Q5T6V5; B2RPI6; Q8N2B1; Q9BT18
Background:
Queuosine 5'-phosphate N-glycosylase/hydrolase, also known as Q-nucleotide N-glycosylase 1 or Queuine salvage protein QNG1, plays a crucial role in the metabolism of queuosine (Q), a modified nucleobase found in tRNA. It catalyzes the hydrolysis of queuosine 5'-phosphate, facilitating the salvage of queuine from exogenous sources. This enzyme exhibits specificity for the queuine base, underscoring its unique function in cellular processes.
Therapeutic significance:
Understanding the role of Queuosine 5'-phosphate N-glycosylase/hydrolase could open doors to potential therapeutic strategies.